Dyne Therapeutics Insider Sold Shares Worth $7,101,120, According to a Recent SEC Filing
28 april, 09:09
28 april, 09:09
03:09 AM EDT, 04/28/2026 (MT Newswires) -- Jason P Rhodes, Director, on April 23, 2026, sold 384,549 shares in Dyne Therapeutics (DYN) for $7,101,120. Following the Form 4 filing with the SEC, Rhodes has control over a total of 1,206,026 common shares of the company, with 1,206,026 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1818794/000157701426000004/xslF345X05/form4-04272026_100429.xml
28 april, 09:09
03:09 AM EDT, 04/28/2026 (MT Newswires) -- Jason P Rhodes, Director, on April 23, 2026, sold 384,549 shares in Dyne Therapeutics (DYN) for $7,101,120. Following the Form 4 filing with the SEC, Rhodes has control over a total of 1,206,026 common shares of the company, with 1,206,026 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1818794/000157701426000004/xslF345X05/form4-04272026_100429.xml
Analys
Rapporter
Analys
Rapporter
1 DAG %
Senast
OMX Stockholm 30
0,66%
(vid stängning)
OMX Stockholm 30
1 DAG %
Senast
3 060,48